Biology of Business

Intellia Therapeutics

Biotechnology

By Alex Denne

Intellia Therapeutics is a leading genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company's platform enables precise gene editing to treat genetic diseases and cancer.

Related Mechanisms for Intellia Therapeutics

First-Mover Advantage

New Content

Sign up to be notified when new content is published.

Notify Me →